Glioblastoma trials in France

In France 37 Also abroad 424

37 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 1Taking people
Anti-GD2 ADC M3554 in Advanced Solid Tumors
Where
Bordeaux, Lille, Lyon, Nice
Age
18 years and over
People
65 worldwide
Run by
EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT06641908 · EU 2024-513687-26-00
Phase 2/3Taking people
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Where
Bron, Marseille, Paris
Age
18 years and over
People
2,250 worldwide
Run by
Global Coalition for Adaptive Research
See details and how to joinNCT03970447 · EU 2024-511452-40-00
No phaseNot yet taking people in France
An Optimization Study Evaluating Safety and Efficacy of the Y-90 Glioblastoma (GBM) Device in Patients With Recurrent GBM
Where
Bron, Marseille
Age
18 years and over
People
30 worldwide
Run by
Boston Scientific Corporation
See details and how to joinNCT07867886
Phase 1Not yet taking people in France
Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable high grade gliomas patients
Where
Amiens Cedex 2, Angers, Bordeaux Cedex, Caen Cedex 5, LE HAVRE, Le Havre Cedex, Lorient, Lyon, Paris, Rouen Cedex, Saint-Herblain Cedex, Toulouse
Age
18 years and over
People
91
Run by
Centre Francois Baclesse
See details and how to joinNCT03212742 · EU 2024-514144-85-02
Phase 1/2Taking people
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Where
Angers, Bordeaux, Lyon, Marseille, Villejuif
Age
Up to 25 years
People
75 worldwide
Run by
Turning Point Therapeutics, Inc.
See details and how to joinNCT04094610 · EU 2023-506464-14-00
No phaseNot yet taking people in France
Impact of Fluorescence-Guided Resection and Chemoradiotherapy on the Systemic Immune Response in Glioblastoma: A Kinetic Analysis of Immune Biomarkers.
Where
Lille
Age
18 years and over
People
17
Run by
University Hospital, Lille
See details and how to joinNCT07568782
No phaseNot yet taking people in France
Impact of Pesticide Exposure on Survival and Tumor Aggressiveness in Patients With Glioblastoma: A Prospective Clinical Study
Where
Toulouse
Age
18 years and over
People
120
Run by
Institut Claudius Regaud
See details and how to joinNCT07788430
No phaseTaking people
A Study to Better Understand the Biological and Molecular Mechanisms Involved in Glioblastoma Recurrence and Progression
Where
Bordeaux
Age
18 years and over
People
45
Run by
University Hospital, Bordeaux
See details and how to joinNCT07173829
Phase 1Not yet taking people in France
RIVKAL clinical trial for the first-in-human administration of BIM2b in participants with Glioblastoma
Where
Clamart
Age
18 years and over
People
36
Run by
Beta Innov
See details and how to join2023-508662-15-00 · EU 2023-508662-15-00
Phase 1/2Taking people
New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study
Where
Besançon, Marseille, Paris, Paris Cedex 13, Rennes Cedex
Age
18 years to 75 years
People
35
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06622434 · EU 2024-514567-26-00
Phase 3Taking people
Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
Where
Amiens Cedex 1, Bron, Clermont Ferrand Cedex1, Lille Cedex, Nice, Paris, Paris Cedex 13, St Herblain, Strasbourg
Age
18 years and over
People
411 worldwide
Run by
European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT05904119 · EU 2023-505267-36-00
No phaseTaking people
Assessment of Early Post-operative Nuclear Imaging in Neurosurgery: a Safety and Feasibility Study in Patients Operated for Glioblastoma
Where
Créteil
Age
18 years and over
People
15
Run by
Beta Emitting Accurate Monitored Systems
See details and how to joinNCT07274397
No phaseNot yet taking people in France
Cerebral Connectivity and Metabolic Phenotype of Gliomas: Prospective Addition of DTI and Rs-fMRI to a Preoperative FDG PET Strategy, With Neuropsychological Correlates and Post-treatment Follow-up
Where
Strasbourg
Age
18 years and over
People
80
Run by
Centre Paul Strauss
See details and how to joinNCT07628257
No phaseNot yet taking people in France
Impact of Androgen Signaling on the Composition of the Immune Microenvironment in Glioblastomas
Where
Paris
Age
18 years to 55 years
People
40
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07472387
No phaseTaking people
Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma
Where
Toulouse
Age
18 years and over
People
80
Run by
Institut Claudius Regaud
See details and how to joinNCT06222138
Phase 2Taking people
Simultaneous Integrated Boost FDOPA Positron Emission Tomography (PET) Guided in Patients With Partially- or Non-operated Glioblastoma
Where
Nancy, Strasbourg, Vandœuvre-lès-Nancy
Age
18 years and over
People
75
Run by
Centre Paul Strauss
See details and how to joinNCT05653622
Phase 2Taking people
Contribution From PET-DOPA in Glioblastoma Re-irradiation - A Randomized Phase II Study
Where
Nancy, Strasbourg
Age
18 years and over
People
54
Run by
Centre Paul Strauss
See details and how to joinNCT05653635
Phase 2Taking people
Surgery for Recurrent Glioblastoma
Where
Dijon, Lyon, Marseille, Nice, Paris, Saint-Etienne, Strasbourg, Tours
Age
18 years and over
People
120 worldwide
Run by
Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT02394626
No phaseTaking people
Prospective Cohort of Patients With Newly Diagnosed Glioblastoma: Analysis of MMP2 and MMP9 Expression and Correlation to Neuro-imaging Features.
Where
Marseille
Age
18 years and over
People
100
Run by
Assistance Publique Hopitaux De Marseille
See details and how to joinNCT03526822
No phaseTaking people
Study of Prognostic Biomarkers of Survival at 6 Months for Patients Treated With Bevacizumab Glioblastomas in First Relapse After Failure of Radiochemotherapy
Where
Amiens
Age
18 years and over
People
170
Run by
Centre Hospitalier Universitaire, Amiens
See details and how to joinNCT03144167
Phase 2Not yet taking people in France
Evaluation of UCPVax Vaccine +/- Pembrolizumab Combined With Standard Treatment as Adjuvant Therapy in Patients With Unmethylated MGMT Glioblastoma
Where
Besancon Cedex, Dijon, Marseille, Paris
Age
18 years and over
People
98
Run by
Centre Hospitalier Universitaire de Besancon
See details and how to joinNCT07347210 · EU 2024-514399-42-00
No phaseTaking people
Control Cohort CTRL COH
Where
Bron
Age
18 years and over
People
350
Run by
Hospices Civils de Lyon
See details and how to joinNCT05370079
Phase 2Taking people
Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide
Where
Bron, Marseille, Paris, Suresnes
Age
18 years and over
People
640 worldwide
Run by
Hopital Foch
See details and how to joinNCT04945148 · EU 2024-511026-31-01
No phaseNot yet taking people in France
Correlative Analysis Between Magnetic Resonance Spectroscopy (MRS) and Essential Clinicobiological Data in Glioblatoma Multiforme (GBM)
Where
Amiens
Age
18 years and over
People
30
Run by
Centre Hospitalier Universitaire, Amiens
See details and how to joinNCT07211841
No phaseTaking people
Deciphering Mechanisms Underlying Cancer Immunogenicity
Where
Toulouse
Age
18 years and over
People
1,100
Run by
Institut Claudius Regaud
See details and how to joinNCT03958240